Interstitial Magnetic Resonance Lymphography Using Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid in Rabbits With Lymph Node Metastasis
Authors:
- Natsuko TsudaNTNatsuko Tsuda
- Takashi TsujiTTTakashi Tsuji
- Naoki KatoNKNaoki Kato
- 1 May 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 40 (5) , 306-312
Abstract
To investigate the dose dependency of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for interstitial magnetic resonance (MR) lymphography and the detection of lymph node metastasis in rabbits. Eighteen VX2 tumor-bearing rabbits were subjected to MR lymphography using clinical MRI equipment. The enhancement of popliteal lymph nodes was studied in these rabbits before and at 2.5 to 10 minutes after the subcutaneous administration of 4, 8, or 17 μmol Gd/kg of Gd-EOB-DTPA in TSE and 3D-FLASH (n = 6). Signal-to-noise ratio and contrast-to-noise ratio were statistically compared between each group by the Tukey test. After MR imaging, the popliteal lymph nodes were removed, and sections were prepared for microscopic examination. In the histologic findings, all metastases (3–12 mm) in the popliteal lymph nodes were detected by 3D-FLASH images. Gd-EOB-DTPA-enhanced T1WI showed a hypointense region for metastasis and a hyperintense region for nontumor regions, although the lymph nodes containing metastasis were detected as a hyperintense region by conventional PDWI and T2WI. Signal enhancement of the nontumor regions and contrast between the nontumor regions and metastasis showed dose dependency and reached a plateau at 8 μmol Gd/kg on T1WI (signal-to-noise ratio: 13.9 ± 1.6; contrast-to-noise ratio: −12.7 ± 1.7). This study showed that interstitial MR lymphography with Gd-EOB-DTPA can detect metastasis and that the optimal dose in rabbits is 8 μmol Gd/kg as a subcutaneous application.Keywords
This publication has 34 references indexed in Scilit:
- Potential for Differential Diagnosis with Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced Magnetic Resonance Imaging in Experimental Hepatic TumorsInvestigative Radiology, 2004
- Assessment of normal, inflammatory, and tumor‐bearing lymph nodes with contrast‐enhanced interstitial magnetic resonance lymphography: Preliminary results in rabbitsJournal of Magnetic Resonance Imaging, 2003
- Interstitial Magnetic Resonance Lymphography Using a Polymeric T1 Contrast AgentInvestigative Radiology, 2002
- MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation.American Journal of Roentgenology, 1999
- Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphographyAdvanced Drug Delivery Reviews, 1999
- Sentinel Lymph Node Biopsy in Breast Cancer: Guidelines and Pitfalls of Lymphoscintigraphy and Gamma Probe DetectionJournal of the American College of Surgeons, 1998
- MR Lymphography with a Lymphotropic T1‐Type MR Contrast Agent: Gd‐DTPA‐PGMMagnetic Resonance in Medicine, 1995
- Benign Lymph Node Hyperplasia and Lymph Node Metastases in RabbitsInvestigative Radiology, 1994
- Nodal size of metastatic squamous cell carcinoma of the neckThe Laryngoscope, 1993
- A new lipophilic gadolinium chelate as a tissue‐specific contrast medium for MRIMagnetic Resonance in Medicine, 1991